Search Within

Charles Rudin

  1. "Radiology, Department of"
Formats
  1. Journal Article (53)
  2. Meeting Abstract (41)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (94)
  2. Department of Medicine (94)
  3. GSK Faculty (94)
  4. Radiology, Department of (94)
  5. Solid Tumor Oncology Division (94)
  6. Thoracic Oncology (94)

More Groups

People
  1. Mark Kris (40)
  2. Andrew Plodkowski (32)
  3. Michelle Ginsberg (26)
  4. Bob Li (25)
  5. Gregory Riely (25)
  6. Michael Offin (25)

More People

Years
  1. 2024 (9)
  2. 2023 (9)
  3. 2022 (11)
  4. 2021 (9)
  5. 2020 (15)
  6. 2019 (12)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Journal of Thoracic Oncology (15)
  3. Clinical Cancer Research (12)
  4. Cancer Discovery (6)
  5. JCO Precision Oncology (4)
  6. Journal of Nuclear Medicine (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. American Association for Cancer Research (21)
  3. Elsevier Inc. (21)
  4. Nature Publishing Group (4)
  5. Oxford University Press (4)
  6. Society of Nuclear Medicine (4)

More Publishers

Results (94)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
    Journal Article

    Skoulidis, F.; Araujo, H. A.; Do, M. T.; Qian, Y.; Sun, X.; Cobo, A. G.; Le, J. T.; Montesion, M.; Palmer, R.; Jahchan, N.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Early circulating tumor DNA shedding kinetics for prediction of platinum sensitivity in patients with small cell lung cancer
    Journal Article

    Murciano-Goroff, Y. R.; Hui, A. B. Y.; Araujo Filho, J. A.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Bonilla, R. F.; Lebow, E. S.; Gomez, D.; Rimner, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study
    Meeting Abstract

    Offin, M.; Lavin, Y.; Zatzman, M.; Sauter, J. L.; Ceglia, N.; Travis, W. D.; Aly, R. G.; Rimner, A.; Shepherd, A.; Simone, C. B. 2nd; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis
    Journal Article

    Moore, Z. R.; Huang, X.; Lobaugh, S.; Zhang, Z.; Wong, P.; Geyer, A.; Pagano, A.; Rudin, C. M.; Jones, D. R.; Gomez, D. R.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer
    Meeting Abstract

    Rimner, A.; Lok, B.; Gelblum, D. Y.; Kotecha, R. R.; Albrecht, F.; Shin, J. Y.; Laplant, Q.; Namakydoust, A.; Shepherd, A.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save